Treatments

The Enovid/VirX/FabiSpray nitric oxide nasal spray (NONS) looks promising, but we need more data to fully understand both safety and effectiveness. One thing is clear – this spray won’t make you bulletproof. It should be seen as a layer of protection, not a replacement for other precautions or treatments. This spray is available in several Read more…

Paxlovid! If you are over 50 or have another risk factor, MAKE A PLAN today for when you test positive for COVID-19. TL;DR: Paxlovid is an oral antiviral pill that stops the virus that causes COVID-19 from making copies of itself in your body. Don’t be afraid of “rebound.” Rebound of COVID symptoms can happen Read more…

Previously, the US Food and Drug Administration (FDA) authorized a combo of monoclonal antibodies, tixagevimab plus cilgavimab (aka Evusheld), as a medication to prevent COVID-19 for people who could not get a vaccine for medical reasons or have weakened immune systems. The goal of Evusheld was to prevent (not treat!) COVID-19 by giving extra lab-made Read more…

Bad news! Because the Omicron subvariants of COVID-19 have become dominant in the US, there are NO monoclonal antibodies currently authorized to treat COVID-19. The newer circulating variants of COVID-19, called BQ.1 and BQ.1.1 have taken over, accounting for about 68% of all the circulating COVID-19 virus. This isn’t great news for us. Our last Read more…

The short answer is YES. Paxlovid remains an important treatment option for people at high risk for bad outcomes from COVID-19 infection, specifically people over age 50. If you have COVID-19 and are at high risk for complications, Paxlovid is definitely worth discussing with a clinician. While the original Paxlovid clinical trials were conducted in Read more…

A: Evusheld helps prevent COVID infections for up to 6 months. Despite the ~7 million Americans who are significantly immunocompromised, only 400,000 doses have been administered so far, suggesting a lack of awareness among patients and doctors. Evusheld is a combination of two monoclonal antibodies authorized as a PREVENTATIVE treatment for people with compromised immune Read more…

As COVID-19 cases are on the rise in many parts of the world, now seems like a good time to review treatment options. Treatment options depend on how sick someone is. For this post, we are going to give the run down treatments for adults across the clinical spectrum of disease (from no symptoms at Read more…

While effective and generally safe, Paxlovid does have the potential for some side effects. One temporary, but particularly distasteful side effect reported is “Paxlovid mouth.” Paxlovid (Nirmatrelvir + Ritonavir) has become a household name since its March 2022 Emergency Use Authorization (EUA) approval as an at-home option to treat COVID-19. It consists of a 5 Read more…